Radical Ventures Research
Investment Thesis
Radical Ventures operates under the core thesis: "AI Eats Software." The firm believes that over the next decade, virtually every bit of software will be replaced by artificial intelligence. Traditional software is hard-coded and static, shipping with fixed features until the next version. AI-powered software learns and improves in real-time, adapting to new situations and delivering superior efficiency and effectiveness.
The firm invests in founders and entrepreneurs who understand the transformational power of AI and are building solutions that leverage artificial intelligence to reshape how we live, work, and play. Radical's investment approach is grounded in deep expertise in deep learning and AI, with founders who have been building AI companies since before the Deep Learning revolution began a decade ago.
Stage and Check Size Focus
Radical Ventures primarily invests at the early stage:
- Pre-Seed to Seed: Early-stage AI companies with founding teams and initial concepts
- Series A: Companies with product-market fit and early traction
- Selective follow-on investments in successful portfolio companies
Based on portfolio analysis, typical check sizes range from $1M to $25M, with a primary focus on $2M-$10M seed and early Series A investments.
Geographic Focus
Radical has a truly global footprint:
- Primary: Toronto (headquarters), San Francisco
- Secondary: London, New York
- Investment scope: North America, Europe, with selective international investments
The firm's Canadian roots and strong connections to Toronto tech ecosystem position it well for finding exceptional founders globally, with particular strength in identifying AI talent from research institutions.
Sector Classification
While Radical invests across AI-enabled sectors, their portfolio heavily concentrates in:
Primary Sectors:
- LLM & Generative AI: Cohere, Reka, Writer, Twelve Labs, You.com (language models, generative AI)
- AI Infrastructure & Developer Tools: CentML, Hebbia, Latent Labs, DataStream-like companies (AI infrastructure, data pipelines)
- AI for Biotech/Healthcare: Genesis Therapeutics, Nabla Bio, Aspect Biosystems, Ubenwa (AI-driven drug discovery, healthcare applications)
- AI for Climate & Materials: Chemix, Orbital Materials, ClimateAi, Picxel (climate solutions, materials science)
- AI for Robotics & Autonomy: Covariant, Promise Robotics, Waabi (robotics, autonomous systems)
Secondary Sectors:
- Healthcare (AI-enhanced applications): Intrepid Labs, Slingshot AI, Signal 1, Pocket Health
- Enterprise Software (AI-first): Various software companies
- Space Tech (AI applications): Muon Space, Picxel
- Financial Services (AI-powered): Hebbia, OffDeal
Portfolio & Recent Activity
Portfolio Scale: 70+ active portfolio companies
Fund Status: Actively deploying from $650M Fund IV (closed October 2025)
Recent High-Profile Investments:
- January 2026: Lead investment in Outset's $30M Series B (AI-moderated healthcare)
- 2025: Investments in Crusoe, Ribbon, Vizcom, World Labs, Periodic Labs, Unblocked, P-1 AI, Prepared, Outset (expansion)
- 2024: World Labs, Latent Labs, Spara, Emerald AI
- 2023: Artificial Agency, DatologyAI, Delphina, Firsthand, Reka, Solver
Notable Exits & Liquidity Events:
- Covariant (2024): Robotics AI, acquired
- Untether AI (2025): Exited
- Prepared (2025): Exited
- Solver (2025): Exited
- CentML (2025): Exited
- RoadBotics (2022): Early exit
Major Partnership Success:
- Nabla Bio: Secured multi-year partnership with Takeda Pharmaceutical, potentially worth $1B+
- Cohere: Valued at $5.5B USD (as of 2025), one of the world's leading LLM companies
Investment Approach & Process
Decision Process: Partnership-based with involvement from multiple partners depending on sector expertise
Lead Tendency: Primarily leads early-stage rounds, with frequent co-lead participation in Series A
Typical Involvement: Active board participation or observer rights, with some advisory roles
Founder Preferences:
- Technical founders with deep AI/ML expertise
- Researchers with published work in AI/deep learning
- Teams with diverse expertise (technical + business)
- Founders solving real, urgent problems with AI
- Track record at major tech companies or academic institutions preferred
Anti-thesis:
- Non-technical founding teams for deep-tech AI
- Companies without clear AI-powered competitive advantage
- Solutions without significant defensibility
Team & Resources
Founding Team:
- Jordan Jacobs (Co-Founder & Managing Partner)
- Tomi Poutanen (Co-Founder & Partner)
Notable Team Members:
- Dr. Fei-Fei Li (Scientific Partner) - Computer vision pioneer, Stanford AI pioneer
- John Megrue (Vice Chair, Partner)
- 35+ additional partners, principals, and operational staff
Special Resources:
- Radical Masterclass: Educational program featuring AI pioneers (Geoffrey Hinton, Yoshua Bengio, Fei-Fei Li, Andrew Ng)
- Velocity Team: Specialized team focused on building within portfolio companies
- Radical Thinking: Blog and content platform with original research and AI insights
Fund History
- Fund I: ~$13M (pre-seed and seed stage)
- Fund II: $471M (focused on AI)
- Fund III: [Intermediate fund]
- Fund IV: $650M USD (October 2025 close, over-subscribed)
Total AUM: Approximately $1B+ across active funds
Market Position & Industry Standing
Radical Ventures is recognized as one of the world's leading early-stage AI venture capital firms. The firm's unique positioning includes:
- AI Expertise: Founded by deep learning pioneers with decade+ of AI investing experience
- Canadian Anchor: Toronto-based but with global reach, particularly strong in AI research communities
- Scientific Advisory: Access to AI luminaries including Geoffrey Hinton (Turing Award winner)
- Portfolio Success: Cohere valuation ($5.5B+) and multiple exits demonstrate fund performance
- Thought Leadership: Regular publications and educational content on AI trends
- Network Effects: Strong relationships with researchers, founders, and institutions globally
Key Investment Considerations
Why Founders Choose Radical:
- Deep AI expertise and scientific credibility
- Patient capital with long-term orientation
- Access to AI pioneers and researchers
- Global network and resources
- Hands-on support through Velocity team
Deal Flow: Primarily inbound from referrals, academic institutions, and founder networks. Exceptional sourcing capabilities in AI research communities.
Competitive Positioning
Radical competes with other premier early-stage AI funds but maintains distinct advantages:
- Early mover advantage in AI-focused investing
- Unique scientific credibility with AI researchers
- Strong Canadian anchor with global reach
- Track record of successful AI outcomes
- Ability to write large checks ($10M-$25M+) for early-stage AI companies
Recent Market Activity
As of early 2026, Radical Ventures remains one of the most active early-stage AI investors, with deployment from the $650M Fund IV continuing strong. The firm's recent investments in healthcare AI (Outset) and infrastructure play (Crusoe) reflect its continued focus on AI applications across verticals.